Literature DB >> 1326521

The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities.

B Zhang1, R A Roth.   

Abstract

In 1989, Shier and Watt identified a gene which was predicted to encode a new member of the insulin receptor (IR) family, and they called it the insulin receptor-related receptor (IRR) (Shier, P., and Watt, V. M. (1989) J. Biol. Chem. 264, 14605-14608). However, the tissues expressing this receptor, its ligand binding specificity and its signaling capability have remained unknown. In the present studies we report Northern blot analyses and polymerase chain reaction data, which indicate that the IRR mRNA is expressed in a variety of tissues, including the human kidney, heart, skeletal muscle, liver, and pancreas. In order to examine the ligand(s) recognized by IRR, we constructed a chimeric receptor with the extracellular domain of the IR replaced with that of IRR. This chimera was found not to bind radioactively labeled insulin, insulin-like growth factor I (IGF-I), or IGF-II. These ligands and relaxin, the only other known member of the mammalian insulin family, also failed to stimulate the tyrosine kinase activity of this chimeric receptor. A second chimeric receptor with the extracellular domain of IR and the kinase domain of IRR was also constructed and utilized to study the signaling capabilities of the kinase domain of IRR. This chimera exhibited high affinity insulin binding and insulin-stimulated tyrosine kinase activity. The kinase domains of the IR and IRR were found capable of phosphorylating the same spectrum of exogenous and endogenous substrates. However, Chinese hamster ovary (CHO) cells stably overexpressing the kinase domain of IRR exhibited elevated basal thymidine incorporation and 2-deoxyglucose uptake compared with CHO cells and CHO cells overexpressing wild-type IR. We conclude that: 1) IRR is expressed in the human kidney, heart, skeletal muscle, liver, and pancreas, 2) IRR does not appear to be the receptor of any known member of the insulin family, and 3) the tyrosine kinase of IRR appears to be similar to that of IR in both the spectrum of substrates phosphorylated and the biological responses stimulated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326521

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family.

Authors:  S B Pierce; M Costa; R Wisotzkey; S Devadhar; S A Homburger; A R Buchman; K C Ferguson; J Heller; D M Platt; A A Pasquinelli; L X Liu; S K Doberstein; G Ruvkun
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

2.  Effect of changes in ambient pH on phosphorylation of cellular proteins.

Authors:  I E Deev; K P Vasilenko; E Zh Kurmangaliev; O V Serova; N V Popova; Yu S Galagan; E B Burova; S A Zozulya; N N Nikol'skii; A G Petrenko
Journal:  Dokl Biochem Biophys       Date:  2006 May-Jun       Impact factor: 0.788

3.  The differential effects of pp120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor.

Authors:  P Soni; M Lakkis; M N Poy; M A Fernström; S M Najjar
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Insulin-like growth factor II stimulates cell proliferation through the insulin receptor.

Authors:  A Morrione; B Valentinis; S Q Xu; G Yumet; A Louvi; A Efstratiadis; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor.

Authors:  T Kitamura; Y Kido; S Nef; J Merenmies; L F Parada; D Accili
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

6.  Insulin receptor-related receptor as an extracellular alkali sensor.

Authors:  Igor E Deyev; Fabien Sohet; Konstantin P Vassilenko; Oxana V Serova; Nadezhda V Popova; Sergey A Zozulya; Elena B Burova; Pascal Houillier; Dmitry I Rzhevsky; Anastasiya A Berchatova; Arkady N Murashev; Anton O Chugunov; Roman G Efremov; Nikolai N Nikol'sky; Eugenio Bertelli; Dominique Eladari; Alexander G Petrenko
Journal:  Cell Metab       Date:  2011-06-08       Impact factor: 27.287

7.  Association of the insulin receptor and phosphatidylinositol 3-kinase requires a third component.

Authors:  R Liu; J N Livingston
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

8.  The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase.

Authors:  S Pons; T Asano; E Glasheen; M Miralpeix; Y Zhang; T L Fisher; M G Myers; X J Sun; M F White
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

9.  Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer.

Authors:  P Massoner; M Ladurner-Rennau; I E Eder; H Klocker
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

10.  Distinct beta-subunits are present in hybrid insulin-like-growth-factor-1 receptors in the central nervous system.

Authors:  A M Moss; J N Livingston
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.